Evidence map›Paper›PMID 32179124›Full record

SynthesisTravel medicine and infectious disease

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.

Alfonso J Rodriguez-Morales, Jaime A Cardona-Ospina, Estefanía Gutiérrez-Ocampo, Rhuvi Villamizar-Peña, Yeimer Holguin-Rivera, Juan Pablo Escalera-Antezana, Lucia Elena Alvarado-Arnez, D Katterine Bonilla-Aldana, Carlos Franco-Paredes, Andrés F Henao-Martinez and 15 more

10 registry-linked trialsOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 10 registered trials, which are not on this map. Cited by 1,170 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,170citing papers in PubMed, 11 pooled it
59.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04338100 completednot on this map

Point Of Care UltraSonography to Perform Risk-stratification of Patients With Suspected or Confirmed COVID-19 - POCUSCO Study

TypeobservationalSponsorUniversity Hospital, AngersRan2020 to 2020Enrolled307ConditionsCOVID, Coronavirus InfectionArmsFollow-up at 14 days
NCT04345289 phase3terminatednot on this map

Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial

TypeinterventionalSponsorThomas BenfieldRan2020 to 2021Enrolled147ConditionsCOVID, Corona Virus Infection, Viral PneumoniaArmsConvalescent anti-SARS-CoV-2 plasma, Infusion placebo
NCT04380870 unknown statusnot on this map

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study

TypeobservationalSponsorCenter for Integrated CareRan2020 to 2025Enrolled500ConditionsCoronavirus InfectionArmsChinese Herbal Medicine
NCT04513158 phase2terminatednot on this map

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection

TypeinterventionalSponsorJoseph M. Flynn, D.O., MPHRan2020 to 2021Enrolled2ConditionsCovid19ArmsConvalescent Plasma
NCT04627467 phase2completednot on this map

Prophylaxis With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19)

TypeinterventionalSponsorFundacion Clinica Valle del LiliRan2020 to 2021Enrolled3,217ConditionsCovid19ArmsChloroquine
NCT04894617 phase3unknown statusnot on this map

Amantadine for COVID-19: A Randomized, Placebo Controlled, Double-blinded, Clinical Trial

TypeinterventionalSponsorCopenhagen University Hospital, HvidovreRan2021 to 2022Enrolled226ConditionsCovid19ArmsAmantadine, Lactose monohydrate
NCT04981743 naunknown statusnot on this map

Evaluation of The Efficacy of Nigella Sativa Versus VitaminD3 as Supplement Therapy in Management of Coronavirus Disease 2019 (COVID-19)

TypeinterventionalSponsorAin Shams UniversityRan2021 to 2021Enrolled100ConditionsCovid19ArmsNigella Sativa capsule twice daily
NCT05302973 nacompletednot on this map

Effects of Aerobic Exercise in People With Post-COVID-19: a Randomized Controlled Trial

TypeinterventionalSponsorIstituti Clinici Scientifici Maugeri SpARan2021 to 2023Enrolled30ConditionsCOVID-19ArmsConventional rehabilitation, Aerobic exercise
NCT05685966 unknown statusnot on this map

Retrospective Study of COVID-19 on Reproductive Function and Assisted Reproductive Technology Pregnancy Outcome in China

TypeobservationalSponsorJinling Hospital, ChinaRan2023 to 2024Enrolled400ConditionsCOVID-19Armsno intervention
NCT05685992 unknown statusnot on this map

The Effects and Underlying Mechanisms of Novel Coronavirus Infection on Reproductive Function and Assisted Pregnancy Outcome

Typeobservational_patient_registrySponsorJinling Hospital, ChinaRan2023 to 2024Enrolled400ConditionsCOVID-19 InfectionArmsno intervention
3 · Its place in the literature

Who cites it

1,170 citing papers in PubMed, 11 syntheses or guidelines pooled it, 2,488 citations in OpenAlex.

  1. Neurocognitive Impairment in Long COVID: A Systematic Review.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Osegnet-F-Unext: O-Segnet-Fusion-Unext for pulmonary lobe segmentation of Covid-19 using Computed Tomography image.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

1,110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 14 countries.

Alfonso J Rodriguez-MoralesPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Comittee on Tropical Medicine, Zoonoses and Travel Medicina, Asociación Colombiana de Infectología, Bogotá, DC, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Pereira, Risaralda, Colombia; Master in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru. Electronic address: arodriguezm@utp.edu.co.
Jaime A Cardona-OspinaPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Comittee on Tropical Medicine, Zoonoses and Travel Medicina, Asociación Colombiana de Infectología, Bogotá, DC, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Pereira, Risaralda, Colombia; Grupo de Investigación Infección e Inmunidad, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia; Semillero de Investigación en Infecciones Emergentes y Medicina Tropical, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Emerging Infectious Diseases and Tropical Medicine Research Group, Instituto para la Investigación en Ciencias Biomédicas - Sci-Help, Pereira, Risaralda, Colombia.
Estefanía Gutiérrez-OcampoPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Rhuvi Villamizar-PeñaPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Yeimer Holguin-RiveraPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Juan Pablo Escalera-AntezanaUniversidad Franz Tamayo/UNIFRANZ, Cochabamba, Bolivia; National Responsible for Telehealth Program, Ministry of Health, La Paz, Bolivia.
Lucia Elena Alvarado-ArnezUniversidad Franz Tamayo/UNIFRANZ, Cochabamba, Bolivia.
D Katterine Bonilla-AldanaPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia; Comittee on Tropical Medicine, Zoonoses and Travel Medicina, Asociación Colombiana de Infectología, Bogotá, DC, Colombia; Incubator in Zoonosis (SIZOO), Biodiversity and Ecosystem Conservation Research Group (BIOECOS), Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia.
Carlos Franco-ParedesCommitte on Travel Medicine, Pan-American Association of Infectious Diseases (API), Pereira, Risaralda, Colombia; Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, USA; Hospital Infantil de México Federico Gómez, México City, Mexico.
Andrés F Henao-MartinezDivision of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Alberto Paniz-MondolfiCommitte on Travel Medicine, Pan-American Association of Infectious Diseases (API), Pereira, Risaralda, Colombia; Laboratory of Medical Microbiology, Department of Pathology, Molecular and Cell-based Medicine, The Mount Sinai Hospital-Icahn School of Medicine at Mount Sinai, New York, USA; Laboratorio de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Caracas, Venezuela; Academia Nacional de Medicina, Caracas, Venezuela; Instituto de Investigaciones Biomedicas IDB / Incubadora Venez/olana de la Ciencia, Cabudare, Edo. Lara, Venezuela.
Guillermo J Lagos-GrisalesPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Eduardo Ramírez-VallejoPublic Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia.
Jose A SuárezComittee on Tropical Medicine, Zoonoses and Travel Medicina, Asociación Colombiana de Infectología, Bogotá, DC, Colombia; Investigador SNI Senacyt Panamá, Clinical Research Deparment, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá City, Panama.
Lysien I ZambranoDepartment of Physiological and Morphological Sciences, School of Medical, Sciences, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa, Honduras.
Wilmer E Villamil-GómezComittee on Tropical Medicine, Zoonoses and Travel Medicina, Asociación Colombiana de Infectología, Bogotá, DC, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Pereira, Risaralda, Colombia; Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre, Colombia; Programa del Doctorado de Medicina Tropical, SUE Caribe, Universidad del Atlántico, Barranquilla, Colombia.
Graciela J Balbin-RamonMaster in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru; Hospital de Emergencias Jose Casimiro Ulloa, Lima, Peru.
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Harapan HarapanMedical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
Kuldeep DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, 243 122, Bareilly, Uttar Pradesh, India.
Hiroshi NishiuraGraduate School of Medicine, Hokkaido University, Kita 15 Jo Nishi 7 Chome, Kita-ku, Sapporo-shi, Hokkaido, 060-8638, Japan.
Hiromitsu KataokaHamamatsu University School of Medicine, Internal Medicine 3rd Division, Department of Cardiology, Hamamatsu, Shizuoka, Japan.
Tauseef AhmadDepartment of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, 210009, China; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Ranjit SahDepartment of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org
Technological University of Pereira · COAsociación Colombiana de Infectología · COSoutheast University · CNUniversidad Privada Franz Tamayo · BOHamamatsu University School of Medicine · JPHokkaido University · JPHospital de Emergencias Jose Casimiro Ulloa · PEHospital Infantil de México Federico Gómez · MXIcahn School of Medicine at Mount Sinai · USIndian Veterinary Research Institute · INNational Autonomous University of Honduras · HNSaudi Aramco Medical Services Organization · SASyiah Kuala University · IDUniversidad Científica del Sur · PEUniversity of Colorado Anschutz Medical Campus · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAn epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 in China leading to a Public Health Emergency of International Concern (PHEIC). Clinical, laboratory, and imaging features have been partially characterized in some observational studies. No systematic reviews on COVID-19 have been published to date.

methodsWe performed a systematic literature review with meta-analysis, using three databases to assess clinical, laboratory, imaging features, and outcomes of COVID-19 confirmed cases. Observational studies and also case reports, were included, and analyzed separately. We performed a random-effects model meta-analysis to calculate pooled prevalences and 95% confidence intervals (95%CI).

results660 articles were retrieved for the time frame (1/1/2020-2/23/2020). After screening, 27 articles were selected for full-text assessment, 19 being finally included for qualitative and quantitative analyses. Additionally, 39 case report articles were included and analyzed separately. For 656 patients, fever (88.7%, 95%CI 84.5-92.9%), cough (57.6%, 95%CI 40.8-74.4%) and dyspnea (45.6%, 95%CI 10.9-80.4%) were the most prevalent manifestations. Among the patients, 20.3% (95%CI 10.0-30.6%) required intensive care unit (ICU), 32.8% presented with acute respiratory distress syndrome (ARDS) (95%CI 13.7-51.8), 6.2% (95%CI 3.1-9.3) with shock. Some 13.9% (95%CI 6.2-21.5%) of hospitalized patients had fatal outcomes (case fatality rate, CFR).

conclusionCOVID-19 brings a huge burden to healthcare facilities, especially in patients with comorbidities. ICU was required for approximately 20% of polymorbid, COVID-19 infected patients and hospitalization was associated with a CFR of >13%. As this virus spreads globally, countries need to urgently prepare human resources, infrastructure and facilities to treat severe COVID-19.

Indexed as

BetacoronavirusCoronavirus InfectionsCoughCOVID-19FeverHospitalizationHumansIntensive Care UnitsPandemicsPneumonia, ViralRespiratory Distress SyndromeSARS-CoV-2Clinical featuresCoronavirus disease 2019EpidemicLaboratoryOutcomesSARS-CoV-2

Identifiers

PMID32179124
PMCPMC7102608
OpenAlexW3009951436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 4 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.